|
Emcure Pharmaceuticals consolidated net profit rises 33.73% in the September 2026 quarter> |
|
Emcure Pharmaceuticals to conduct board meeting> |
|
Board of Emcure Pharmaceuticals approves draft scheme of amalgamation> |
|
Emcure Pharmaceuticals allots 11,400 equity shares under ESOS> |
|
Emcure Pharmaceuticals schedules AGM> |
|
Emcure receives EIR report for its formulations facility at Sanand, Gujarat> |
|
Emcure Pharmaceuticals consolidated net profit rises 42.05% in the June 2026 quarter> |
|
Emcure Pharmaceuticals fixes record date for final dividend> |
|
Emcure Pharmaceuticals completes acquisition of balance 12.05% stake in Gennova> |
|
Emcure Pharmaceuticals to hold board meeting> |